These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20501475)

  • 21. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community.
    Schnabel RB; Larson MG; Yamamoto JF; Sullivan LM; Pencina MJ; Meigs JB; Tofler GH; Selhub J; Jacques PF; Wolf PA; Magnani JW; Ellinor PT; Wang TJ; Levy D; Vasan RS; Benjamin EJ
    Circulation; 2010 Jan; 121(2):200-7. PubMed ID: 20048208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation.
    Conen D; Wong JA; Sandhu RK; Cook NR; Lee IM; Buring JE; Albert CM
    JAMA Cardiol; 2016 Jul; 1(4):389-96. PubMed ID: 27438314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinogen and albumin levels and risk of atrial fibrillation in men and women (the Copenhagen City Heart Study).
    Mukamal KJ; Tolstrup JS; Friberg J; Grønbaek M; Jensen G
    Am J Cardiol; 2006 Jul; 98(1):75-81. PubMed ID: 16784925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-sensitivity troponin I in persistent atrial fibrillation - relation to NT-proBNP and markers of inflammation and haemostasis.
    Horjen AW; Ulimoen SR; Norseth J; Svendsen JH; Smith P; Arnesen H; Seljeflot I; Tveit A
    Scand J Clin Lab Invest; 2018 Sep; 78(5):386-392. PubMed ID: 29933716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular inflammation in healthy women: multilevel associations with state-level prosperity, productivity and income inequality.
    Clark CR; Ridker PM; Ommerborn MJ; Huisingh CE; Coull B; Buring JE; Berkman LF
    BMC Public Health; 2012 Mar; 12():211. PubMed ID: 22433166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of plasma oxidative status and inflammation with the development of atrial fibrillation in patients presenting with ST elevation myocardial infarction.
    Bas HA; Aksoy F; Icli A; Varol E; Dogan A; Erdogan D; Ersoy I; Arslan A; Ari H; Bas N; Sutcu R; Ozaydin M
    Scand J Clin Lab Invest; 2017 Apr; 77(2):77-82. PubMed ID: 27905214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome, inflammation, and risk of symptomatic peripheral artery disease in women: a prospective study.
    Conen D; Rexrode KM; Creager MA; Ridker PM; Pradhan AD
    Circulation; 2009 Sep; 120(12):1041-7. PubMed ID: 19738135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
    Pradhan AD; Shrivastava S; Cook NR; Rifai N; Creager MA; Ridker PM
    Circulation; 2008 Feb; 117(6):823-31. PubMed ID: 18227386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory Biomarkers in Atrial Fibrillation.
    Zacharia E; Papageorgiou N; Ioannou A; Siasos G; Papaioannou S; Vavuranakis M; Latsios G; Vlachopoulos C; Toutouzas K; Deftereos S; Providência R; Tousoulis D
    Curr Med Chem; 2019; 26(5):837-854. PubMed ID: 28748764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Incidence, prevalence, and mortality estimates for chronic atrial fibrillation in Turkish adults].
    Uyarel H; Onat A; Yüksel H; Can G; Ordu S; Dursunoğlu D
    Turk Kardiyol Dern Ars; 2008 Jun; 36(4):214-22. PubMed ID: 18765964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study.
    Adamsson Eryd S; Smith JG; Melander O; Hedblad B; Engström G
    Eur J Epidemiol; 2011 Jun; 26(6):449-55. PubMed ID: 21424216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity and the risk of new-onset atrial fibrillation.
    Wang TJ; Parise H; Levy D; D'Agostino RB; Wolf PA; Vasan RS; Benjamin EJ
    JAMA; 2004 Nov; 292(20):2471-7. PubMed ID: 15562125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased plasma level of soluble urokinase plasminogen activator receptor is associated with incidence of heart failure but not atrial fibrillation.
    Borné Y; Persson M; Melander O; Smith JG; Engström G
    Eur J Heart Fail; 2014 Apr; 16(4):377-83. PubMed ID: 24464777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid profile and incidence of atrial fibrillation: A prospective cohort study in China.
    Li X; Gao L; Wang Z; Guan B; Guan X; Wang B; Han X; Xiao X; Waleed KB; Chandran C; Wu S; Xia Y
    Clin Cardiol; 2018 Mar; 41(3):314-320. PubMed ID: 29575115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis.
    Liu T; Li G; Li L; Korantzopoulos P
    J Am Coll Cardiol; 2007 Apr; 49(15):1642-1648. PubMed ID: 17433956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a Basic Risk Score for Incident Atrial Fibrillation in a Japanese General Population　- The Suita Study.
    Kokubo Y; Watanabe M; Higashiyama A; Nakao YM; Kusano K; Miyamoto Y
    Circ J; 2017 Oct; 81(11):1580-1588. PubMed ID: 28539563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients.
    Kaireviciute D; Blann AD; Balakrishnan B; Lane DA; Patel JV; Uzdavinys G; Norkunas G; Kalinauskas G; Sirvydis V; Aidietis A; Lip GY
    Thromb Haemost; 2010 Jul; 104(1):122-7. PubMed ID: 20458440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Menopausal age, postmenopausal hormone therapy and incident atrial fibrillation.
    Wong JA; Rexrode KM; Sandhu RK; Moorthy MV; Conen D; Albert CM
    Heart; 2017 Dec; 103(24):1954-1961. PubMed ID: 28988211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation.
    Korantzopoulos P; Kolettis TM; Kountouris E; Dimitroula V; Karanikis P; Pappa E; Siogas K; Goudevenos JA
    Int J Cardiol; 2005 Jul; 102(2):321-6. PubMed ID: 15982504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin C Intravenous Treatment In the Setting of Atrial Fibrillation Ablation: Results From the Randomized, Double-Blinded, Placebo-Controlled CITRIS-AF Pilot Study.
    Trankle CR; Puckett L; Swift-Scanlan T; DeWilde C; Priday A; Sculthorpe R; Ellenbogen KA; Fowler A; Koneru JN
    J Am Heart Assoc; 2020 Feb; 9(3):e014213. PubMed ID: 32013700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.